Enhertu

{
  "id": "MLC-T-ONC-002848",
  "term": "Enhertu",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat adults with certain types of HER2-positive or HER2-low breast cancer, HER2-positive stomach cancer, gastroesophageal junction cancer, or other solid tumor, or non-small cell lung cancer that has a certain mutation in the HER2 gene. It is also being studied in the treatment of other types of cancer. Enhertu contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some cancer cells. It also contains an anticancer drug called deruxtecan, which may help kill cancer cells. Enhertu is a type of antibody-drug conjugate. Also called fam-trastuzumab deruxtecan and trastuzumab deruxtecan.",
  "synonyms": [
    "fam-trastuzumab deruxtecan",
    "trastuzumab deruxtecan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/enhertu/"
}